Dietary Supplement
Lacidofil
Lacidofil is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
2
50%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 42 (50.0%)
Trials by Status
not_yet_recruiting125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia
NCT06990568
completedphase_2
Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia
NCT04473079
completedphase_4
Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly
NCT03695432
completedphase_3
Emergency Department Probiotic Treatment of Pediatric Gastroenteritis
NCT01853124
Clinical Trials (4)
Showing 4 of 4 trials
NCT06990568Phase 4
Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia
NCT04473079Phase 2
Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia
NCT03695432Phase 4
Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly
NCT01853124Phase 3
Emergency Department Probiotic Treatment of Pediatric Gastroenteritis
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4